Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis

PURPOSE: To describe 1-year clinical results of intravitreal ranibizumab treatment in patients with choroidal neovascularization secondary to exudative age-related macular degeneration (AMD) and to evaluate whether early treatment is a predictive value for prognosis of the disease. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Canan, Handan, Sızmaz, Selçuk, Altan-Yaycıoğlu, Rana, Sarıtürk, Çağla, Yılmaz, Gürsel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894137/
https://www.ncbi.nlm.nih.gov/pubmed/24453484
http://dx.doi.org/10.2147/CIA.S56863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894137/
https://www.ncbi.nlm.nih.gov/pubmed/24453484
http://dx.doi.org/10.2147/CIA.S56863

Ejemplares similares